Tricyclic antidepressants and pharmacogenetics
Also known as: Tricyclics
Which antidepressant fits my genetics best?
Depending on your genotype, these 14 medications split into up to 3 groups, from take-as-directed through to worth avoiding. Gene2Rx Pro reads CYP2B6 and CYP2C19 and CYP2D6 from your own report and tells you which is which.
Why pharmacogenetics matter for tricyclic antidepressants
Tricyclic antidepressants (TCAs) predate SSRIs and remain in use for depression, chronic pain, migraine prevention, and some sleep conditions. Nearly all TCAs are cleared by CYP2D6 and CYP2C19, often in sequence: one enzyme produces an active metabolite, the other clears it. That means TCA dosing is uniquely sensitive to pharmacogenetic variation, and both CPIC and the FDA publish phenotype-based dose guidance.[1][2]
TCAs have a narrower therapeutic window than SSRIs, so getting the dose right matters more. Poor CYP2D6 metabolizers can reach toxic plasma levels on doses that are routine for normal metabolizers, which is one of the main reasons TCAs have fallen out of first-line use despite generally being as effective as SSRIs for depression.[3]
Key genes in this class
- CYP2D6Cytochrome P450 2D6CYP2D6 is the most clinically important pharmacogene. It metabolizes around a quarter of all prescription drugs, including many antidepressants, opioids, and stimulants. The gene is unusually variable: roughly 7 percent …
- CYP2C19Cytochrome P450 2C19CYP2C19 handles several SSRIs (citalopram, escitalopram, sertraline), proton pump inhibitors (omeprazole, esomeprazole), and the blood thinner clopidogrel. About 2 percent of people of European ancestry and 13 percent of people …
Medications in this class covered by Gene2Rx
Explore each medication's genetic findings, supporting sources, and report information.
Brand products in the TCAs class
Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.
References
- CPIC. CPIC Guideline for Tricyclic Antidepressants and CYP2D6 and CYP2C19 (2016). cpicpgx.org
- U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
- PharmGKB / Stanford University. PharmGKB: The Pharmacogenomics Knowledge Base. pharmgkb.org
Which tcas is right for your genetics?
Informational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.